Literature DB >> 7551657

The incidence of juvenile dermatomyositis: results from a nation-wide study.

D P Symmons1, J A Sills, S M Davis.   

Abstract

There have been no previous attempts to estimate the incidence of juvenile dermatomyositis (JDM) in the UK and Ireland. Consultant paediatricians from these countries were asked to report all cases of JDM which were diagnosed in 1992 and 1993 to the British Paediatric Surveillance Unit. One-hundred-and-twenty-one reports were received, of which 48 were confirmed cases of JDM and three were confirmed cases of polymyositis. The estimated incidence of JDM was 1.9 per million children aged under 16 yr (95% confidence interval 1.4-2.6). The median age at onset was 6.8 yr and the median delay in diagnosis was 4 months. Girls were affected much more often than boys (ratio 5.0:1). In the cases with an onset in 1992 there appeared to be a cluster of cases with an onset in April and May.

Entities:  

Mesh:

Year:  1995        PMID: 7551657     DOI: 10.1093/rheumatology/34.8.732

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  36 in total

Review 1.  Long-term outcomes in juvenile dermatomyositis: how did we get here and where are we going?

Authors:  Adam Huber; Brian M Feldman
Journal:  Curr Rheumatol Rep       Date:  2005-12       Impact factor: 4.592

2.  Juvenile dermatomyositis: new insights and new treatment strategies.

Authors:  Neil Martin; Charles K Li; Lucy R Wedderburn
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-02       Impact factor: 5.346

Review 3.  Juvenile dermatomyositis.

Authors:  Michelle Batthish; Brian M Feldman
Journal:  Curr Rheumatol Rep       Date:  2011-06       Impact factor: 4.592

Review 4.  Outcome Scores in Pediatric Rheumatology.

Authors:  Gabriella Giancane; Silvia Rosina; Alessandro Consolaro; Nicolino Ruperto
Journal:  Curr Rheumatol Rep       Date:  2021-03-08       Impact factor: 4.592

Review 5.  Sex Differences in Pediatric Rheumatology.

Authors:  Marco Cattalini; Martina Soliani; Maria Costanza Caparello; Rolando Cimaz
Journal:  Clin Rev Allergy Immunol       Date:  2019-06       Impact factor: 8.667

Review 6.  [Juvenile dermatomyositis].

Authors:  F Dressler; H-I Huppertz
Journal:  Z Rheumatol       Date:  2006-11       Impact factor: 1.372

7.  Autoantibodies in children with juvenile dermatomyositis: A single centre experience from North-West India.

Authors:  Altaf Hussain; Amit Rawat; Ankur Kumar Jindal; Anju Gupta; Surjit Singh
Journal:  Rheumatol Int       Date:  2017-03-22       Impact factor: 2.631

8.  A national registry for juvenile dermatomyositis and other paediatric idiopathic inflammatory myopathies: 10 years' experience; the Juvenile Dermatomyositis National (UK and Ireland) Cohort Biomarker Study and Repository for Idiopathic Inflammatory Myopathies.

Authors:  Neil Martin; Petra Krol; Sally Smith; Kevin Murray; Clarissa A Pilkington; Joyce E Davidson; Lucy R Wedderburn
Journal:  Rheumatology (Oxford)       Date:  2010-09-07       Impact factor: 7.580

9.  Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis.

Authors:  H Gunawardena; L R Wedderburn; H Chinoy; Z E Betteridge; J North; W E R Ollier; R G Cooper; C V Oddis; A V Ramanan; J E Davidson; N J McHugh
Journal:  Arthritis Rheum       Date:  2009-06

10.  Clinical characteristics and outcomes of juvenile and adult dermatomyositis.

Authors:  Sang-Jun Na; Seung Min Kim; Il Nam Sunwoo; Young-Chul Choi
Journal:  J Korean Med Sci       Date:  2009-07-30       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.